Estrogen hits the surface

Nature Medicine

Volumn 5, Issue 10, 1999, Pages 1130-1131

  Collins, Peter ^a   Webb, Carolyn ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

CELL NUCLEUS; CELL PROLIFERATION; CYTOSOL; ENZYME ACTIVATION; ESTROGEN ACTIVITY; ESTROGEN BINDING; ESTROGEN SYNTHESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 0032853929     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/13453     Document Type: Short Survey

References (11)

1. Razandi, M., Pedram, A., Greene, G.L. & Levin, E.R. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ER alpha and ER beta expressed in Chinese hamster ovary cells. Mol. Endocrinol. 13, 307-319 (1999).
2. Chen, Z. et al. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J. Clin. Invest. 103, 401-406 (1999).
3. Goetz, R.M. et al. Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 96, 2788-2793 (1999).
4. Garcia-Cardena, G., Fan R., Shah V., et al. Dynamic activation of endothelial nitric oxide synthase Hsp90. Nature 392, 821-824 (1998).
5. Williams, J.K., Adams, M.R., Herrington, D.M. & Clarkson, T.B. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J. Am. Coll. Cardiol. 20, 452-457 (1992).
6. Collins, P. et al. 17 beta-Estradiol attenuates acetyl-choline-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 92, 24-30 (1995).
7. Singer, C.A., Figueroa-Masot, X.A., Batchelor, R.H. & Dorsa, D.M. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J. Neurosci. 19 2455-2463 (1999).
8. Kawas, C. et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore longitudinal study of aging. Neurology 48, 1517-1521 (1997).
9. Migliaccio, A., Di DM, Castoria G., et al. Tyrosine kinase/p21ras/MAP kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15, 1292-1300 (1996).
10. Improta-Brears, T. et al. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc. Natl. Acad. Sci. USA 96, 4686-4691 (1999).
11. Endoh, H. et al. Rapid activation of MAP kinase by estrogen in the bone cell line. Biochem. Biophys. Res. Commun. 235, 99-102 (1997).